FindTrial
Sign In

Application of MRI in patients with non-alcoholic fatty liver disease

Application of non-invasive imaging techniques, MRI-PDFF and MR elastography, to nonalcoholic fatty liver patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004307
Enrollment
100
Registered
2019-10-14
Start date
2019-09-21
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Male or female confirmed as fatty liver by imaging test within 6 months from 19 to 75 years

Exclusion criteria

Exclusion criteria: Those who lost more than 10% of their previous weight within 6 months. Those who have received diet or exercise therapy that may affect the results of human testing within 3 months of screening. HBsAg, HCVAb positive factor. Those who have accompanying diseases such as eating disorders (anorexia, bulimia) Those who have received drugs or diuretics, amphetamine, cyproheptadine, phenothiazine, appetite suppressants, or appetite enhancers or consumed probiotics within 2 weeks prior to screening. With hepatic malignant disease and acute systemic inflammation and infection

Design outcomes

Primary

MeasureTime frame
Liver fat mass using MRI-PDFF (%)—

Secondary

MeasureTime frame
Intrahepatic Fibrosis with MR elastography (kPa)—

Countries

Korea, Republic of

Contacts

Public ContactDae Won Jun

Hanyang University

gongori1004@gmail.com+82-2-2290-8303

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026